Exam 4 Flashcards
Drugs
Heparin
Anti-coagulant. Enhances antithrombin activity (1000x) which inhibits Xa and thrombin. Reversed by protamine sulfate.
LMW heparin
Anti-coagulant, enhances antithrombin and is more specific for factor Xa inactivation.
Fondaparinux
Anti-coagulant, increases antithrombin. The least efficacious.
Protamine sulfate
Reversal agent for heparin.
Hirudin/ Lepirudin
Anti-coagulant. Derived from leeches also can be made recombinantly. Binds to both active and substrate sites on thrombin.
Argatroban
Direct thrombin inhibitor.
Dabigatran
Bind to thrombin active sites.
Warfarin
Direct thrombin inhibitor. Prevents synthesis of factors 2, 7, 9 ,10 via tampering with redox metabolism of vitamin K. Reversed by vitamin K, factor 9, FFP
Rivaorxaban
Factor Xa inhibitor.
Apixaban
Factor Xa inhibitor.
tPA
Fibrinolytic. Rapidly lyses thrombi. Treatment for ischemic strokes.
Streptokinase
Fibrinolytic
Urokinase
Fibrinolytic
Aspirin
COX inhibitor. Acetylation of Serine 529 residue irreversibly modifies COX1 enzyme from binding with arachidonic acid to form prostaglandins and TXA2. Less platelet aggregation and has some anti-inflammatory effects. High incidence of GI ulcers.
Clopidogrel
ADP inhibitor. Anti-platelet aggregation.
Abiciximab
Mab anti-platelet aggregation.
vitamin K
For warfarin overdose. Helps replenish factors.
Fresh frozen plasma
To replenish factors. For hemophilia.
Aminocaproic acid
Fibrinolytic inhibitor. Targets plasminogen pathway. Clot stabilizer. Used post-operatively.
Tranexamic acid
Anti-fibrinolytic used for massive hemorrhage/ trauma to help stop bleeding.
Lispro and Aspart
Rapid acting insulin
Humulin
Short acting insulin
Neutral Protamine Hagedorn
intermediate acting insulin
Glargine and Detemir
Long acting insulin
Metformin
Biguanides. Inhibits gluconeogenesis.
Sulfonylureas
Insulin secretagogue. Blocks the K+ channel in the beta cells causing insulin release. Black box warnings for increased cardiovascular events.
Thiazolidinediones (TZD’s)
Decreases insulin resistance by increasing insulin signal transduction.
Acarbose
Alpha-glucosidase inhibitor. Blocks digestion of complex carbs.
Bile acid binding resin
Sticks to cholesterol and glucose in bile acids and excretes them.
Amylin
Made by beta cells, suppresses glucagon release from the alpha cells
Semaglutide
GLP-1 agonist, which increases insulin release and decreases glucagon release.
Statin
HMG-CoA reductase inhibitor. Side effects: muscle pain.
Gliflozin
SGLT2 inhibitor. Prevents glucose reabsorption in the proximal convoluted tubule.
Sitagliptin
(Januvia) combination therapy in NIDDM. DPP4 inhibitor (DPP4 inhibits GLP-1).
Niacin
Inhibits VLDL from leaving the hepatocytes. Side effects: flushing, itching, dry skin.
Gemfibrozil
A fibrate. Increases lipolysis in the liver. Decreases VLDL and LDL a little.
Ezetimibe
Blocks uptake of dietary cholesterol.
Evolocomab
PCSK9 inhibitor. Allows more receptors to get recycled to pull more LDL out of the blood. Very effective when used with a statin.
Celecoxib
COX2 selective inhibitor, no effect on constitutive COX1
Meloxicam
COX2 selective inhibitor. Less effective than celebrex.
Diclofenac
COX and LOX inhibitor. Can be given topically for arthritic pain.
Ibuprofen
NSAID. Used for pain and to decrease inflammatory response. COX1 and COX2 inhibition. Causes less GI upset than aspirin.
Indomethacin
COX and LOX inhibitor. Used for arthritis, gout, and patent ductus arteriosus.
Ketorolac
Toradol. COX inhibitor. Used for severe pain in sports medicine. Helps decrease need for opioids.
Acetaminophen
COX2 inhibition in the CNS. Can be used for headache (vasoconstriction in the brain) and fever (peripheral vasodilation).
Glucocorticoids
Suppress inflammation. Increase Annexin 1, SLP-1, IL-10 and decrease NFkB.
Morphine
Phenanthrene opioid strong agonist
Dilaudid
Phenanthrene opioid strong agonist
Codeine
phenanthrene opioid moderate agonists
Oxycodone
moderate agonist phenanthrene opioid
Percocet
Moderate opioid agonist. Combination of acetaminophen and oxycodone.
Methadone
Phenylheptylamine opioid strong agonist